However, in the MetS group, we observed dose-dependent variations in UCP2 expression: there was a significantly lower mRNA expression of UCP2 with the lower dose of RSV + QRC was used and an increase with RSV 50 + QRC 0.95 (p < 0.05, Figure 1C). The gene discussed is UCP2; the disease is metabolic syndrome.